Our study revealed that the expression of specific genes, including TNFRSF1B, TRADD2, and MAP3K7, may play an important role in chemotherapy resistance in peripheral T-cell lymphoma. This evidence concerns the gene MAP3K7 and peripheral T-cell lymphoma, not otherwise specified.